By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – In a study set to appear online this week in the Proceedings of the National Academy of Sciences, researchers from the US and Japan report that they have linked an immune-cell receptor called CD44 to type 2 diabetes using an expression-based genome-wide association study, or eGWAS, strategy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.